The genetic epidemiology of melanocortin 4 receptor variants

Ruth J F Loos1

  • 1Medical Research Council Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, P.O. Box 285, Cambridge, CB5 8QD, United Kingdom. ruth.loos@mrc-epid.cam.ac.uk

Insights

Common variants in the melanocortin 4 receptor (MC4R) gene influence body weight and obesity risk in the general population. Large studies confirm MC4R variants significantly reduce obesity risk, impacting BMI and body weight.

Area of Science:

  • Genetics and Genomics
  • Metabolic Disorders
  • Obesity Research

Background:

  • Rare mutations in the melanocortin 4 receptor (MC4R) gene are a primary cause of monogenic obesity.
  • Increasing evidence suggests common MC4R variants also contribute to obesity susceptibility in the general population.
  • Previous studies on specific MC4R variants (V103I, I251L) yielded inconclusive results due to small sample sizes.

Purpose of the Study:

  • To investigate the contribution of common MC4R variants to obesity risk in the general population.
  • To analyze the association of MC4R variants with Body Mass Index (BMI) and obesity.
  • To explore the potential regulatory role of genetic variants near the MC4R gene.

Main Methods:

  • Meta-analyses of candidate gene studies for MC4R variants V103I and I251L.
  • Genome-wide association studies (GWAS) to identify common variants associated with BMI and obesity.
  • Analysis of variant frequencies, effect sizes on BMI, body weight, and obesity risk.

Main Results:

  • Large-scale meta-analyses confirmed that MC4R variants V103I and I251L significantly reduce obesity risk (by -21% and -50%, respectively).
  • GWAS identified a common variant downstream of MC4R strongly associated with BMI and obesity risk in adults and children.
  • This common variant increases BMI, body weight, and obesity risk, and is also associated with increased height.

Conclusions:

  • Common MC4R variants play a significant role in determining BMI and obesity risk across the general population.
  • Genetic variants near the MC4R gene, potentially influencing its regulation, contribute to obesity.
  • These findings highlight the importance of MC4R in both rare and common forms of obesity.

Related Concept Videos

Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...